Exelixis, Inc. Banner Image

Exelixis, Inc.

  • Ticker EXEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Exelixis, Inc. Logo Image
  • 51-200 Employees
  • Based in Alameda, California
Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously.
Exelixis, Inc.

Most Recent Responsibility Report

Exelixis, Inc.
MOST RECENT 2022 Corporate Values & Sustainability Report

Exelixis, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Exelixis, Inc. Sustainability Report, Exelixis, Inc. Corporate Social Responsibility Report, Exelixis, Inc. CSR Report, Exelixis, Inc. Corporate Responsibility, Exelixis, Inc. CR Report, Exelixis, Inc. Citizenship Report, Exelixis, Inc. ESG Report, and Exelixis, Inc. Environmental Report online.
Exelixis, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!